Integra LifeSciences Holdings Corporation Financial Ratios — IART

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	11.32	14.62	-7.22	11.4	-1.52	40.52	25.53	19.14	13.41	28.71	27.43	22.86	7.41	-0.74	-75.66
Return on Assets (%)	2.59	3.57	-1.79	2.45	-0.21	4.16	2.58	1.92	1.57	3.87	4.57	4.71	1.77	-0.18	-13.52
Return on Capital (%)	7.71	7.28	- -	6.36	-0.1	10.97	- -	- -	5.35	- -	9.2	9.18	4.32	- -	- -
Return on Invested Capital (%)	5.62	5.71	- -	4.54	0.64	6.43	- -	- -	4.74	- -	4.78	5.98	2.79	- -	- -
Gross Margin (%)	61.65	62.16	59.88	61.98	63.01	64.81	63.35	61.19	62.79	62.03	61.24	62.29	57.39	54.77	50.86
EBITDA Margin (%)	13.47	15.21	9.53	14.35	15.68	18.95	11.26	15.06	17.67	19.49	20.56	22.93	15.25	10.51	10.39
Operating Margin (%)	7.04	8.88	5.08	8.52	9.02	11.63	3.77	7.54	10.46	11.03	12.79	15.34	7.23	1.76	1.1
Incremental Operating Margin (%)	-91.19	37.15	28.66	32.52	13.64	32.7	-35.96	23.29	105.68	5.01	26.88	273.95	791.61	-120.54	-42.14
Pretax Margin (%)	3.65	6.26	2.7	5.72	6.87	9.11	0.96	3.9	3.96	6.82	13.92	13.73	5.26	-1.13	-34.46
Profit Margin (%)	3.59	4.96	-3.02	4.27	-0.4	7.52	5.45	4.13	3.31	9.76	10.96	11.59	4.39	-0.43	-31.58
Net Income to Common Margin (%)	3.59	4.96	-3.02	4.27	-0.4	7.52	5.45	4.13	3.31	9.76	10.96	11.59	4.39	-0.43	-31.58
Effective Tax Rate (%)	1.77	20.81	- -	20.35	88.71	17.52	- -	- -	16.48	- -	21.24	15.59	16.44	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	11.32	14.62	-7.22	11.4	-1.52	40.52	25.53	19.14	13.41	28.71	27.43	22.86	7.41	-0.74	-75.66

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	532	520	392	630	714	665	1,841	1,354	1,458	1,655	1,651	1,615	1,682	1,985	2,033
ST Debt	- -	- -	- -	4	14	- -	60	22	57	159	60	53	30	622	141
LT Debt	532	520	392	626	700	665	1,781	1,332	1,401	1,496	1,592	1,563	1,652	1,363	1,893
Total Debt/EBITDA	5.07	4.11	5.91	5.51	5.16	3.54	13.77	6.11	5.44	6.19	5.21	4.52	7.15	11.72	11.97
Net Debt/EBITDA	4.11	3.34	4.09	4.88	4.81	2.99	12.46	5.48	4.29	4.05	3.26	2.76	5.2	9.19	9.55
Total Debt/EBIT	9.69	7.04	11.08	9.28	8.98	5.77	41.09	12.2	9.19	10.94	8.37	6.76	15.08	69.85	112.99
Net Debt/EBIT	7.86	5.73	7.67	8.23	8.37	4.88	37.19	10.95	7.24	7.16	5.24	4.13	10.97	54.79	90.08
EBITDA to Interest Expense	3.8	5.68	3.37	5.2	5.88	7.29	3.82	3.43	4.97	3.74	6.29	7.2	4.57	2.4	1.97
EBITDA-CapEx/Interest Expense	2.41	2.58	1.22	3.46	4.46	5.45	2.58	2.23	2.48	2.84	5.34	6.25	3.27	0.78	0.86
EBIT to Interest Expense	1.99	3.32	1.79	3.09	3.38	4.47	1.28	1.72	2.94	2.11	3.91	4.82	2.17	0.4	0.21
Interest Expense	28	22	20	22	24	26	35	65	54	72	50	50	51	71	86
Common Equity/Total Assets	22.83	25.99	23.6	19.87	8.27	12.24	8.91	11.24	12.09	14.75	18.49	22.62	25.06	23.3	11.78
Long-Term Debt/Equity (%)	108.04	100.34	58.86	88.91	93.17	79.2	185.09	96.8	98.86	98.78	94.46	86.6	104.03	88.2	181.38
Long-Term Debt/Capital (%)	67.08	63.21	58.22	66.24	81.29	75.04	83.73	78.18	75.41	68.37	67.7	62.62	62.82	46.59	77.01
Long-Term Debt/Total Assets (%)	46.52	44.65	32.89	39.45	39.46	36.78	55.47	42.85	42.4	41.39	42.08	40.17	43.68	33.76	52.54
Total Debt/Equity (%)	108.04	100.34	58.86	89.45	95.08	79.2	191.33	98.43	102.9	109.28	98.01	89.52	105.91	128.43	194.85
Total Debt/Capital (%)	67.08	63.21	58.22	66.64	82.96	75.04	86.55	79.5	78.49	75.64	70.25	64.73	63.96	67.84	82.73
Total Debt/Total Assets (%)	46.52	44.65	32.89	39.69	40.27	36.78	57.33	43.57	44.13	45.79	43.66	41.53	44.47	49.15	56.45
Net Debt to Equity	87.58	81.62	40.75	79.26	88.68	67.04	173.15	88.34	81.11	71.58	61.3	54.68	77.03	100.74	155.35
Net Debt/Capital (%)	62.29	58.29	49.1	63.9	81.95	71.79	85.35	77.68	69.29	63.1	56.21	48.4	51.98	58.11	72.94
EBITDA	105	126	66	114	138	188	134	222	268	267	317	357	235	169	170
EBITDA-CapEx	67	57	24	76	105	141	90	144	134	204	269	310	168	55	74
Operating Income (Loss)	55	74	35	68	80	115	45	111	159	151	197	239	112	28	18

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.99	0.91	1.01	0.57	0.35	0.83	0.5	0.53	0.6	1.17	1.51	1.42	1.01	0.3	0.58
Current Ratio	4.44	4.24	4.37	4.2	3.15	4.01	2.36	2.95	2.59	3.09	3.39	3.62	3.45	1.17	2.54
Quick Ratio	2.15	1.98	2	1.45	1.3	2.02	1.22	1.54	1.43	1.73	2.19	2.24	1.85	0.59	1.19
CFO/Avg Current Liab	0.69	0.57	0.47	0.68	0.79	0.89	0.48	0.65	0.78	0.56	0.84	0.8	0.45	0.21	0.07
Common Equity/Total Assets	22.83	25.99	23.6	19.87	8.27	12.24	8.91	11.24	12.09	14.75	18.49	22.62	25.06	23.3	11.78
Long-Term Debt/Equity (%)	108.04	100.34	58.86	88.91	93.17	79.2	185.09	96.8	98.86	98.78	94.46	86.6	104.03	88.2	181.38
Long-Term Debt/Capital (%)	67.08	63.21	58.22	66.24	81.29	75.04	83.73	78.18	75.41	68.37	67.7	62.62	62.82	46.59	77.01
Long-Term Debt/Total Assets (%)	46.52	44.65	32.89	39.45	39.46	36.78	55.47	42.85	42.4	41.39	42.08	40.17	43.68	33.76	52.54
Total Debt/Equity (%)	108.04	100.34	58.86	89.45	95.08	79.2	191.33	98.43	102.9	109.28	98.01	89.52	105.91	128.43	194.85
Total Debt/Capital (%)	67.08	63.21	58.22	66.64	82.96	75.04	86.55	79.5	78.49	75.64	70.25	64.73	63.96	67.84	82.73
Total Debt/Total Assets (%)	46.52	44.65	32.89	39.69	40.27	36.78	57.33	43.57	44.13	45.79	43.66	41.53	44.47	49.15	56.45
CFO/Total Liabilities	16.01	9.15	10.13	9.46	10.25	12.02	5.09	11.53	12.27	9.71	14.89	12.68	6.38	5.19	1.97
CFO/CapEx	2.72	0.86	1.26	2.18	3.14	2.46	2.63	2.57	1.72	3.19	6.5	5.62	2.09	1.13	0.53
Altman's Z-Score	3.61	3.92	3.81	3.6	4.07	4.88	3.07	3.99	4.04	3.7	4.18	4.01	3.42	2.27	1.92

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	6.96	7.13	5.98	6.97	7.28	7.08	5.94	5.69	5.61	5.48	6.74	6.29	5.9	6.06	5.93
Days Sales Outstanding	52.44	51.19	61.04	52.35	50.17	51.59	61.43	64.15	65.06	66.63	54.11	58.03	61.89	60.25	61.52
Inventory Turnover	1.88	1.83	1.48	1.53	1.63	1.63	1.7	1.98	1.89	1.66	1.91	1.83	1.84	1.78	1.74
Days Inventory Outstanding	194.11	199.12	247.25	238.59	223.87	224.12	215.22	184.16	192.75	219.41	191.57	199.47	198.44	205.11	209.34
Accounts Payable Turnover	11.67	9.78	7.19	7.16	10.96	11.12	8.37	6.53	6.35	6.14	10.39	7.25	7.43	8.79	9.73
Accounts Payable Turnover Days	31.28	37.31	50.75	50.96	33.29	32.82	43.63	55.86	57.49	59.44	35.12	50.32	49.15	41.55	37.5
Cash Conversion Cycle	215.27	213	257.54	239.99	240.74	242.88	233.02	192.45	200.32	226.6	210.56	207.18	211.17	223.81	233.36
Inventory to Cash Days	-141.68	-147.94	-186.21	-186.23	-173.7	-172.53	-153.79	-120.01	-127.69	-152.78	-137.45	-141.44	-136.54	-144.86	-147.82
Inventories	171	172	207	189	211	217	296	280	316	310	317	325	390	429	493
Raw Materials	28	29	36	30	38	39	48	53	66	76	90	82	119	126	131
Work In Process	36	40	47	39	48	50	59	48	48	53	65	71	74	79	99
Finished Goods	107	102	124	120	126	128	190	180	202	180	163	172	196	224	263
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	827	1,089	1,356	1,776	2,504	3,205	3,752	3,809	5,005	5,475	5,674	4,687	3,404	1,750	967
- Cash & Cash Equivalents	101	97	121	72	48	102	175	139	199	470	513	457	276	246	235
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	532	520	392	630	714	665	1,841	1,354	1,458	1,655	1,651	1,615	1,682	1,985	2,033
Enterprise Value	1,259	1,512	1,627	2,334	3,170	3,768	5,418	5,024	6,263	6,660	6,812	5,845	4,777	3,461	2,737
Total Capital	793	822	673	945	861	886	2,127	1,703	1,857	2,189	2,351	2,495	2,629	2,925	2,458
Total Debt/Capital (%)	67.08	63.21	58.22	66.64	82.96	75.04	86.55	79.5	78.49	75.64	70.25	64.73	63.96	67.84	82.73
Total Debt / EV	0.42	0.34	0.24	0.27	0.23	0.18	0.34	0.27	0.23	0.25	0.24	0.28	0.35	0.57	0.74
EV/Sales	1.61	1.82	2.34	2.93	3.59	3.8	4.56	3.41	4.13	4.85	4.42	3.75	3.1	2.15	1.67
EV/EBITDA	11.98	11.96	24.51	20.42	22.9	20.04	40.51	22.66	23.36	24.91	21.48	16.36	20.32	20.44	16.12
EV/EBIT	22.92	20.49	46	34.39	39.83	32.67	120.93	45.26	39.47	44	34.54	24.47	42.83	121.82	152.09
EV/Cash Flow to Firm	9.57	19.71	21.3	23.09	29.49	27.37	17.27	18.73	22.65	21.74	19.35	19.08	26.12	22.15	21.14
EV/Free Cash Flow to Firm	7.41	10.37	13.71	16.74	22.5	20.37	15.17	14.52	15.24	17.99	17.02	16.54	19.13	12.79	12.16
Diluted Market Cap	909	1,111	1,374	1,787	2,504	3,397	3,787	3,809	5,041	5,533	5,727	4,687	3,499	1,750	967
Diluted Enterprise Value	1,341	1,534	1,646	2,346	3,170	3,960	5,453	5,024	6,300	6,718	6,864	5,845	4,904	3,488	2,765
EV per Share	23.46	27.05	28.63	35.64	42.91	50.43	69.11	59.49	72.94	78.97	80.42	69.93	61.11	44.85	35.14
TTM Sales	780	831	697	797	883	992	1,188	1,472	1,518	1,372	1,542	1,558	1,542	1,611	1,635
TTM EBITDA	105	126	66	114	138	188	134	222	268	267	317	357	235	169	170
TTM Operating Income	55	74	35	68	80	115	45	111	159	151	197	239	112	28	18
TTM Cash Flow to Firm	131	77	76	101	108	138	314	268	276	306	352	306	183	156	129
TTM Free Cash Flow to Firm	170	146	119	139	141	185	357	346	411	370	400	353	250	271	225

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	6.37	8.67	14.38	14.66	18.11	20.75	23.96	13.73	13.77	20.67	15.88	15.04	16.92	7.18	6.62
EV/EBIT	22.92	20.49	46	34.39	39.83	32.67	120.93	45.26	39.47	44	34.54	24.47	42.83	121.82	152.09
Enterprise Value	1,259	1,512	1,627	2,334	3,170	3,768	5,418	5,024	6,263	6,660	6,812	5,845	4,777	3,461	2,737
Low Price	14.04	11.54	15.44	21.25	26.44	27.38	40.51	42.33	42.14	34.21	61.84	40.66	33.44	16.81	10.87
EV/Sales	1.61	1.82	2.34	2.93	3.59	3.8	4.56	3.41	4.13	4.85	4.42	3.75	3.1	2.15	1.67
EV/EBITDA	11.98	11.96	24.51	20.42	22.9	20.04	40.51	22.66	23.36	24.91	21.48	16.36	20.32	20.44	16.12
Price/Earnings	29.55	26.43	- -	52.22	- -	42.98	57.95	62.64	99.69	40.89	33.56	25.96	50.25	- -	- -
Price/Earnings Average	40.86	24.32	-54.33	46.01	-651.72	37.55	57.78	80.41	94.85	31.96	34.67	26.36	53.58	-316.99	-2.44
Price/Earnings High	50.71	29.25	-65.07	53.2	-738.21	44.52	68.32	93.75	111.34	42.39	38.77	32.36	70.03	-504.72	-4.09
Price/Earnings Low	26.91	15.66	-41.64	40.92	-555.23	27.43	49.05	58.79	72.08	21.55	30.98	18.83	38.59	-186.8	-1.64
Price/Book Value	3.17	3.6	4.82	5.63	17.06	14.49	13.12	10.9	12.53	10.27	8.11	5.33	3.59	1.86	2.28
Price/Book Value Average	4.38	3.31	4.07	4.96	15.62	12.66	13.08	14	11.92	8.03	8.38	5.41	3.83	2.34	2.97
Price/Book Value High	5.43	3.99	4.87	5.74	17.7	15.01	15.47	16.32	13.99	10.64	9.37	6.64	5.01	3.73	4.98
Price/Book Value Low	2.88	2.13	3.12	4.41	13.31	9.25	11.1	10.23	9.06	5.41	7.49	3.86	2.76	1.38	2
Price/Tangible Book Value	-22.08	95.2	6.19	-24.75	-6.87	-13.81	-3.31	-6.04	-8.79	-13.45	-11.96	-12.98	-6.36	-2.3	-1.37
Price/Tangible Book Value Average	-30.53	87.57	5.22	-21.81	-6.29	-12.07	-3.3	-7.76	-8.37	-10.52	-12.36	-13.18	-6.78	-2.9	-1.78
Price/Tangible Book Value High	-37.89	105.34	6.25	-25.22	-7.12	-14.3	-3.9	-9.05	-9.82	-13.95	-13.82	-16.18	-8.86	-4.62	-2.99
Price/Tangible Book Value Low	-20.1	56.41	4	-19.4	-5.36	-8.81	-2.8	-5.67	-6.36	-7.09	-11.05	-9.41	-4.88	-1.71	-1.2
Price/Sales	1.06	1.31	1.95	2.23	2.84	3.23	3.16	2.59	3.3	3.99	3.68	3.01	2.21	1.09	0.59
Price/Sales Average	1.47	1.21	1.64	1.96	2.6	2.82	3.15	3.32	3.14	3.12	3.8	3.06	2.35	1.37	0.77
Price/Sales High	1.82	1.45	1.97	2.27	2.94	3.35	3.72	3.87	3.68	4.14	4.25	3.75	3.08	2.18	1.29
Price/Sales Low	0.97	0.78	1.26	1.75	2.21	2.06	2.67	2.43	2.38	2.1	3.4	2.18	1.7	0.81	0.52
Price/Cash Flow	7.93	18.43	25.45	21.25	23.88	27.53	32.76	19.07	21.62	26.86	18.16	17.72	24.32	13.53	19.2
Price/Cash Flow Average	10.96	16.95	21.49	18.72	21.87	24.06	32.66	24.48	20.57	21	18.76	18	25.93	17.01	24.97
Price/Cash Flow High	13.6	20.39	25.73	21.65	24.78	28.52	38.61	28.55	24.15	27.84	20.98	22.09	33.9	27.09	41.94
Price/Cash Flow Low	7.22	10.92	16.47	16.65	18.63	17.57	27.73	17.9	15.64	14.15	16.77	12.85	18.68	10.03	16.8
Price/Free Cash Flow Average	8.81	7.98	12.14	12.92	16.59	18.13	23.89	17.62	13.11	16.15	16.41	15.28	18.04	9.03	8.62
Price/Free Cash Flow High	10.93	9.6	14.54	14.94	18.79	21.49	28.24	20.55	15.38	21.42	18.35	18.75	23.57	14.38	14.47
Price/Free Cash Flow Low	5.8	5.14	9.3	11.49	14.13	13.24	20.28	12.88	9.96	10.89	14.66	10.91	12.99	5.32	5.8
EV/Sales Average	2.02	1.71	2.03	2.66	3.35	3.39	4.55	4.15	3.97	3.98	4.54	3.8	3.27	2.45	1.87
EV/Sales High	2.37	1.96	2.36	2.97	3.7	3.91	5.12	4.7	4.51	5	4.99	4.49	3.99	3.26	2.39
EV/Sales Low	1.52	1.29	1.65	2.45	2.97	2.63	4.07	3.25	3.21	2.97	4.13	2.93	2.61	1.88	1.62
EV/EBITDA Average	14.99	11.27	21.33	18.57	21.38	17.89	40.43	27.53	22.45	20.44	22.08	16.57	21.42	23.27	18
EV/EBITDA High	17.61	12.88	24.74	20.71	23.58	20.65	45.53	31.19	25.54	25.66	24.27	19.6	26.16	30.97	23.03
EV/EBITDA Low	11.27	8.45	17.3	17.06	18.93	13.87	36.2	21.6	18.19	15.22	20.11	12.76	17.1	17.93	15.57
EV/EBIT Average	28.69	19.31	40.03	31.28	37.19	29.16	120.68	55	37.94	36.1	35.49	24.77	45.14	138.66	169.85
EV/EBIT High	33.71	22.06	46.43	34.89	41.01	33.66	135.91	62.3	43.16	45.32	39.01	29.3	55.14	184.54	217.35
EV/EBIT Low	21.57	14.47	32.47	28.73	32.92	22.61	108.07	43.15	30.74	26.89	32.33	19.08	36.04	106.84	146.97
Last Price	15.42	19.48	23.86	27.12	33.89	42.9	47.86	45.1	58.28	64.92	66.99	56.07	43.55	22.68	12.42
High Price	26.45	21.56	24.12	27.62	35.16	44.43	56.42	67.5	65.09	67.29	77.4	69.9	60.69	45.42	27.13
Enterprise Value Average	1,575	1,425	1,416	2,123	2,960	3,363	5,407	6,105	6,021	5,465	6,999	5,918	5,035	3,939	3,056
Enterprise Value High	1,851	1,628	1,642	2,367	3,264	3,883	6,089	6,915	6,848	6,860	7,694	7,001	6,149	5,243	3,911
Enterprise Value Low	1,185	1,068	1,149	1,950	2,620	2,608	4,842	4,790	4,877	4,070	6,376	4,558	4,019	3,035	2,645

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	54	56	64	65	74	75	78	85	86	84	85	84	78	77	78
Diluted Weighted Avg Shares	59	57	58	66	74	79	79	84	86	85	85	84	80	77	78
Basic Weighted Avg Shares	54	56	57	65	74	75	78	84	86	84	85	84	78	77	78
Revenue per Share	14.54	14.86	12.26	12.17	11.95	13.28	15.16	17.44	17.67	16.27	18.21	18.64	19.72	20.87	21
EBITDA per Share	1.96	2.26	1.17	1.75	1.87	2.52	1.71	2.63	3.12	3.17	3.74	4.27	3.01	2.19	2.18
Operating Income per Share	1.02	1.32	0.62	1.04	1.08	1.54	0.57	1.31	1.85	1.79	2.33	2.86	1.43	0.37	0.23
Basic EPS, GAAP	0.52	0.74	-0.37	0.52	-0.05	1	0.83	0.72	0.58	1.59	2	2.16	0.87	-0.09	-6.63
Basic EPS from Cont Ops	0.52	0.74	0.39	0.55	0.09	1	0.83	0.72	0.58	1.59	2	2.16	0.87	-0.09	-6.63
Diluted EPS, GAAP	0.47	0.72	-0.37	0.52	-0.05	0.94	0.82	0.72	0.58	1.57	1.98	2.16	0.84	-0.09	-6.63
Diluted EPS from Cont Ops	0.47	0.72	0.38	0.55	0.09	0.94	0.82	0.72	0.58	1.57	1.98	2.16	0.84	-0.09	-6.63
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	1.94	1.06	0.94	1.28	1.42	1.56	1.46	2.36	2.7	2.42	3.69	3.16	1.79	1.68	0.65
Free Cash Flow per Basic Share	1.23	-0.18	0.19	0.69	0.97	0.92	0.91	1.44	1.13	1.66	3.12	2.6	0.94	0.19	-0.58
Cash & Equivalents per Share	1.88	1.73	2.12	1.1	0.65	1.37	2.23	1.64	2.32	5.57	6.06	5.46	3.95	3.55	3.39
Book Value per Share	4.87	5.41	4.95	4.82	1.99	2.96	3.65	4.14	4.65	6.32	8.26	10.53	12.12	12.19	5.45
Tangible Book Value per Share	-0.7	0.2	3.86	-1.1	-4.94	-3.11	-14.48	-7.46	-6.63	-4.83	-5.6	-4.32	-6.85	-9.84	-9.07

Integra LifeSciences Holdings Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)